Travere Therapeutics (TVTX) Depreciation & Amortization (CF) (2012 - 2026)
Travere Therapeutics (TVTX) reported Depreciation & Amortization (CF) of $5.2 million for Q3 2026, down 67.1% from $15.79 million a year earlier but up 22.8% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Travere Therapeutics' Depreciation & Amortization (CF) came in at $52.78 million, down 3.5% year-over-year; for FY2025, it came in at $60.74 million, up 39.5% from FY2024.
- Depreciation & Amortization (CF) has increased for four consecutive years, with a five-year compound annual growth rate of 19.8% (FY2020 to FY2025).
- By year, Depreciation & Amortization (CF) came in at $43.56 million in FY2024 (+13.0%), $38.53 million in FY2023 (+86.0%), $20.72 million in FY2022 (+62.6%) and $12.75 million in FY2021 (-48.1%).
- Five-year quarterly Depreciation & Amortization (CF) spans a low of -$7.82 million in Q4 2021 and a high of $25.21 million in Q1 2026.
- Year over year, Depreciation & Amortization (CF) gained in six of the last eight quarters, with growth averaging 17.9%.
- The high point for year-over-year Depreciation & Amortization (CF) in five years was Q1 2026 (growth of 96.9%); the low point was Q2 2026 (a decline of 69.8%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $4.23 million (Q2 2026), $25.21 million (Q1 2026) and $18.14 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 545.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 192.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 726.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.61 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 132.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.58 Bn |
| 10 | Travere Therapeutics | 4.97 Bn | 4.56 Bn | 221.70 Mn | 5.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.20 Mn |
| Jun 30, 2026 | 4.23 Mn |
| Mar 31, 2026 | 25.21 Mn |
| Dec 31, 2025 | 18.14 Mn |
| Sep 30, 2025 | 15.79 Mn |
| Jun 30, 2025 | 14.02 Mn |
| Mar 31, 2025 | 12.80 Mn |
| Dec 31, 2024 | 12.09 Mn |
| Sep 30, 2024 | 11.24 Mn |
| Jun 30, 2024 | 10.35 Mn |
| Mar 31, 2024 | 9.88 Mn |
| Dec 31, 2023 | 9.49 Mn |
| Sep 30, 2023 | 11.48 Mn |
| Jun 30, 2023 | 10.95 Mn |
| Mar 31, 2023 | 6.62 Mn |
| Dec 31, 2022 | 6.31 Mn |
| Sep 30, 2022 | -793,000.00 |
| Jun 30, 2022 | 8.11 Mn |
| Mar 31, 2022 | 7.09 Mn |
| Dec 31, 2021 | -7.82 Mn |
API Access
Travere Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();